or Try an Advanced Search...

    Technical Analysis for STTK - Shattuck Labs, Inc.

    Grade Last Price % Change Price Change
    F 1.25 -0.79% -0.01
    STTK closed down 0.79 percent on Friday, November 1, 2024, on 33 percent of normal volume.
    Earnings due: Nov 7
    *** please verify all earnings dates ***
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical STTK trend table...
    Date Alert Name Type % Chg
    Narrow Range Bar Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Down 3 Days in a Row Weakness 0.00%
    Down 4 Days in a Row Weakness 0.00%
    Narrow Range Bar Range Contraction -0.79%
    Wide Bands Range Expansion -0.79%
    Down 3 Days in a Row Weakness -0.79%
    20 DMA Resistance Bearish -4.58%
    Narrow Range Bar Range Contraction -4.58%
    Wide Bands Range Expansion -4.58%
    Older End-of-Day Signals for STTK ...

       Recent Intraday Alerts

    Alert Time
    Fell Below Previous Day's Low about 19 hours ago
    Down 1% about 19 hours ago
    10 DMA Resistance about 21 hours ago
    60 Minute Opening Range Breakout about 22 hours ago
    Rose Above 10 DMA about 22 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    STTK Chart by TradingView
    Basic chart:

    Profile

    Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian cancer. It also holds a collaboration agreement with Takeda Pharmaceuticals to develop SL-279252 that is in Phase 1 clinical trial in patients with advanced solid tumors and lymphoma. The company was founded in 2016 and is headquartered in Austin, Texas.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Cancer Life Sciences Solid Tumors Autoimmune Disease Treatment Of Cancer Lymphoma Clinical Research Clinical Trial Ovarian Cancer Advanced Solid Tumors Clinical Pharmacology Treatment Of Ovarian Cancer

    Is STTK a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Oct 24 Down -64.19% in 4 Weeks, Here's Why Shattuck Labs (STTK) Looks Ripe for a Turnaround
    Oct 8 After Plunging -68.96% in 4 Weeks, Here's Why the Trend Might Reverse for Shattuck Labs (STTK)
    Oct 2 Top Midday Decliners
    Oct 2 Shattuck Labs stock craters following pipeline and job cuts
    Oct 2 Shattuck cut to Neutral at Citi on program exit
    Oct 2 STTK Discontinues Cancer Program, Plans Workforce Cut, Stock Falls
    Oct 2 Shattuck Labs Refocuses Strategy Amidst Restructuring and Cuts
    Oct 1 Shattuck Labs Shutters Cancer Program, Lays Off Around 40% Of Its Workforce, Reorganizes Pipeline
    Oct 1 Shattuck plunges after discontinuing lead candidate
    Oct 1 Shattuck Labs Provides Company Update and Announces SL-325, a First-In-Class Death Receptor 3 (DR3) Antagonist Targeting the TL1A/DR3 Signaling Pathway
    See more STTK news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 11.76
    52 Week Low 1.07
    Average Volume 669,274
    200-Day Moving Average 6.19
    50-Day Moving Average 2.54
    20-Day Moving Average 1.35
    10-Day Moving Average 1.29
    Average True Range 0.17
    RSI (14) 28.57
    ADX 46.57
    +DI 10.56
    -DI 34.79
    Chandelier Exit (Long, 3 ATRs) 1.16
    Chandelier Exit (Short, 3 ATRs) 1.58
    Upper Bollinger Bands 1.56
    Lower Bollinger Band 1.13
    Percent B (%b) 0.27
    BandWidth 31.65
    MACD Line -0.35
    MACD Signal Line -0.42
    MACD Histogram 0.0717
    Fundamentals Value
    Market Cap 58.92 Million
    Num Shares 47.1 Million
    EPS -2.24
    Price-to-Earnings (P/E) Ratio -0.56
    Price-to-Sales 323.03
    Price-to-Book 3.76
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.36
    Resistance 3 (R3) 1.36 1.34 1.34
    Resistance 2 (R2) 1.34 1.31 1.33 1.33
    Resistance 1 (R1) 1.29 1.29 1.28 1.29 1.33
    Pivot Point 1.27 1.27 1.26 1.26 1.27
    Support 1 (S1) 1.22 1.24 1.21 1.22 1.17
    Support 2 (S2) 1.20 1.22 1.19 1.17
    Support 3 (S3) 1.15 1.20 1.16
    Support 4 (S4) 1.15